Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 8%
Buy 46%
Hold 38%
Sell 8%
Strong Sell 0%

Bulls say

Henry Schein Inc. demonstrates a positive financial outlook, highlighted by significant growth across its business segments, particularly in the Global Distribution and Value-Added Services segment, which includes essential products and services for dental and medical practitioners. The company's medical products revenue experienced a 4.7% increase, while dental business revenue rose by 5.5%, indicating strong demand in both markets. Additionally, the Global Technology segment reported revenue of $173 million, growing 9.7%, underscoring the company's strategic focus on technology solutions and signaling ongoing expansion potential.

Bears say

Henry Schein Inc reported a gross margin of 30.7% for the quarter, falling short of the expected 31.6%, indicating challenges in maintaining profitability within its Global Distribution and Value-Added Services segment. Additionally, the company's outlook suggests that remeasurement gains will decrease in 2026 compared to 2025, reflecting underlying financial difficulties and an unfavorable mix affecting both distribution and specialty products. Despite some positive contributions from mergers and acquisitions and foreign currency fluctuations, the overall performance points to potential weaknesses that could adversely impact Henry Schein's financial stability.

Henry Schein (HSIC) has been analyzed by 13 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 46% recommend Buy, 38% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Hold based on their latest research and market trends.

According to 13 analysts, Henry Schein (HSIC) has a Hold consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $86.69, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $86.69, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.